BO
Boiron S.A.
BOI.PA · PAR
26.00 € -0.76% (-0.20 €)
1M -1.14%
Market Cap 451.4M €
P/E Ratio 13.83x
Div. Yield 5.19%
ROE 8.63%
Bulios Fair Price
14.45 €
44.4% downside
Current Price
26 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BOI.PA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
95 /100
Cheap P/E 13.83x
EV/EBITDA 6.09x
P/S 0.90x
Growth
3 /100
Declining EPS growth 9.90%
Rev. growth 2.11%
FCF growth 10.54%
Profitability
51 /100
Moderate Gross margin 72.98%
Net margin 6.51%
Op. margin 7.06%
Quality
41 /100
Average ROIC 5.70%
ROE 8.63%
ROA 5.42%
Debt
100 /100
Low Debt/Equity 0.08x
Current ratio 2.22x
Int. coverage 20.84x
Stability
46 /100
Moderate Beta 0.21x
Rev. volatility 5.28%
EPS volatility 136.91%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BOI.PA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Pascal Houdayer
Employees
2,499
Headquarters
Messimy